Intravenous Iron Therapy and Risk for Progressive Loss of Kidney Function in Patients with Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|118|2|c189-c194

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.118, Iss.2, 2010-12, pp. : c189-c194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Intravenous Iron Sucrose to Oral Iron in the Treatment of Anemic Patients with Chronic Kidney Disease Not on Dialysis

By  

Nephron Clin Pract, Vol. 100, Iss. 3, 2005-04 ,pp. : c55-c62

Karger

Access to resources Recommend Favorite

Development of CKD in Japanese LT patients

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 220-227

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Risk of Gallbladder Stone Formation Is Increased in Patients with Predialysis Chronic Kidney Disease but Not Those Undergoing Chronic Hemodialysis Therapy

By  

Nephron Clin Pract, Vol. 111, Iss. 3, 2009-02 ,pp. : c167-c172

Karger

Access to resources Recommend Favorite

Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease

By Dean Bonnie B.   Dylan Michelle   Gano Anacleto   Knight Kevin   Ofman Joshua J.   Levine Barton S.  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 981-988

Informa Healthcare

Access to resources Recommend Favorite

Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease

By Katsiki Niki   Elisaf Moses  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1669-1672

Informa Healthcare

Access to resources Recommend Favorite